Recursion Pharmaceuticals: The AI Drug Discovery Play
9/7 04:56
Recursion Pharmaceuticals (NASDAQ:RXRX) has seen significant share price volatility in 2025, dropping 27% year-to-date and trading over 55% below its 52-week high of $12. Despite this underperformance, the clinical-stage TechBio company continues to garner attention for its innov...